The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-Bromo-4-((3-bromo-4-fluorophenyl)amino)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)quinoline-3-carboxamide ID: ALA4582046
PubChem CID: 155554064
Max Phase: Preclinical
Molecular Formula: C33H22Br2F2N4O4
Molecular Weight: 736.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2nccc(Oc3ccc(NC(=O)c4cnc5ccc(Br)cc5c4Nc4ccc(F)c(Br)c4)cc3F)c2cc1OC
Standard InChI: InChI=1S/C33H22Br2F2N4O4/c1-43-30-14-20-27(15-31(30)44-2)38-10-9-28(20)45-29-8-5-19(13-25(29)37)41-33(42)22-16-39-26-7-3-17(34)11-21(26)32(22)40-18-4-6-24(36)23(35)12-18/h3-16H,1-2H3,(H,39,40)(H,41,42)
Standard InChI Key: OKGDSNFGLXDTLC-UHFFFAOYSA-N
Molfile:
RDKit 2D
45 50 0 0 0 0 0 0 0 0999 V2000
16.9078 -19.7859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9067 -20.6054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6147 -21.0144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6130 -19.3770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3216 -19.7823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3223 -20.6013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0309 -21.0084 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7391 -20.5976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7344 -19.7754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0253 -19.3721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2000 -19.3775 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1987 -21.0135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1980 -21.8307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1998 -18.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0209 -18.5549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7265 -18.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4318 -18.5508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1368 -18.1391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1329 -17.3210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4181 -16.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7160 -17.3304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8379 -16.9078 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5483 -17.3117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5537 -18.1288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.2516 -16.8980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9637 -17.3023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9501 -15.6675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2417 -16.0815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9696 -18.1194 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.6803 -18.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0995 -19.3267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0909 -18.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3805 -18.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3938 -19.7405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6873 -19.3372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0038 -16.9296 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.7942 -18.0891 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
26.8107 -19.7292 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.6622 -16.0718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6659 -16.8868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3724 -17.2894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0758 -16.8781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0682 -16.0599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3611 -15.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7865 -17.2814 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
1 11 1 0
2 12 1 0
12 13 1 0
11 14 1 0
10 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
23 25 1 0
23 24 2 0
25 26 1 0
25 28 2 0
26 40 2 0
39 27 2 0
27 28 1 0
26 29 1 0
29 30 1 0
30 35 2 0
34 31 2 0
31 32 1 0
32 33 2 0
33 30 1 0
34 35 1 0
21 36 1 0
32 37 1 0
31 38 1 0
39 40 1 0
40 41 1 0
41 42 2 0
42 43 1 0
43 44 2 0
44 39 1 0
42 45 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 736.37Molecular Weight (Monoisotopic): 733.9976AlogP: 9.39#Rotatable Bonds: 8Polar Surface Area: 94.60Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 5.89CX LogP: 9.13CX LogD: 9.12Aromatic Rings: 6Heavy Atoms: 45QED Weighted: 0.16Np Likeness Score: -1.20
References 1. Qi B, Xu X, Yang Y, He H, Yue X.. (2019) Optimization and biological evaluation of nicotinamide derivatives as Aurora kinase inhibitors., 27 (17): [PMID:31307762 ] [10.1016/j.bmc.2019.07.016 ]